IDC MarketScape Report Names Mach7 a Leader in U.S. Healthcare Provider VNA/AICA Unstructured Data Platforms for Integrated C...
June 07 2016 - 8:00AM
Business Wire
Mach7 recognized for its’ patient-centric
design, proven interoperability, functional flexibility, and
collaborative customer approach.
Mach7 Technologies (ASX:M7T), a global provider of enterprise
imaging solutions, today announced it has been named a Leader in
the IDC MarketScape: U.S. Healthcare Provider VNA/AICA Unstructured
Data Platforms for Integrated Care 2016 Vendor Assessment (doc
# US41287215, May 2016).
This study focuses on Vendor Neutral and Application-Independent
Clinical Archive (VNA and AICA) platforms that allow providers to
manage and provide access to disparate types of unstructured
content among multiple departments, across the entire integrated
delivery network (IDN), and between affiliated providers in the
community.
Study Highlights Participants, Contenders, Major Players and
Leaders
Using detailed surveys and interviews with end-users, vendors,
and a review board of IDC experts, an accurate and consistent
assessment of each vendor's characteristics, behavior, and
capability was created. Based on the review board’s findings,
vendors were characterized as industry Participants, Contenders,
Major Players or Leaders. Judy Hanover, a research director at IDC
Health Insights and author of the report stated “This report, which
identifies Mach7 Technologies as a Leader in the VNA and AICA
Platform space, focused on many variables including functionality
and patient-centricity of the product, underlying technology,
market knowledge and reach of the vendor, deployment capabilities,
value relative to price, and customer references for the
product."
"The next generation of VNA technologies, AICA, has evolved as a
strategy to support U.S. healthcare organizations moving to
integrated care," Hanover elaborated. "AICA supports the needs of
existing VNA users and systems while offering healthcare providers
additional capabilities to address the challenges posed by the
exponential growth of unstructured healthcare data and the
deepening need for population health management (PHM) and the
patient-centered medical home (PCMH) in new business models.”
“We think about enterprise imaging differently and we’re bold in
our approach”, said Mach7 CTO Eric Rice. “Our culture of innovation
and customer collaboration drives everything that we do. We listen
to our customers and create the solutions that solve their
business, collaboration and interoperability challenges clearing
the way for improved patient care.”
About IDC MarketScape:IDC MarketScape vendor analysis
model is designed to provide an overview of the competitive fitness
of ICT (information and communications technology) suppliers in a
given market. The research methodology utilizes a rigorous scoring
methodology based on both qualitative and quantitative criteria
that results in a single graphical illustration of each vendor's
position within a given market. IDC MarketScape provides a clear
framework in which the product and service offerings, capabilities
and strategies, and current and future market success factors of IT
and telecommunications vendors can be meaningfully compared. The
framework also provides technology buyers with a 360 degree
assessment of the strengths and weaknesses of current and
prospective vendors.
About Mach7 TechnologiesMach7 Technologies (ASX:M7T)
develops innovative enterprise imaging IT solutions that create a
clear and complete view of the patient to inform diagnosis, reduce
care delivery delays and costs, and improve patient
outcomes. Mach7’s award-winning enterprise imaging platform
provides a vendor neutral foundation for unstructured data
consolidation and communication to power interoperability and
enables healthcare enterprises to build their best-of-breed
clinical ecosystems. Mach7’s sophisticated workflow tools,
advanced clinical viewing and optimized vendor neutral
archiving solutions unlock silos of legacy systems empowering
healthcare providers to own, access and share patient data without
boundaries. Visit www.mach7t.com. Follow us
on Twitter, Google+, Facebook,
and LinkedIn.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160607005592/en/
Mach7 TechnologiesJulia Vaughn,
802-768-0143julia.vaughn@mach7t.com
Mach7 Technologies (ASX:M7T)
Historical Stock Chart
From Nov 2024 to Dec 2024
Mach7 Technologies (ASX:M7T)
Historical Stock Chart
From Dec 2023 to Dec 2024